Publication: SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)
No Thumbnail Available
Identifiers
Date
2016-12-01
Authors
de las Penas, R.
Blasco, A.
De Castro, J.
Escobar, Y.
Garcia-Campelo, R.
Gurpide, A.
Lopez-Lopez, R.
Majem, M.
Rodriguez, C. A.
Virizuela, J. A.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Springer international publishing ag
Abstract
Chemotherapy-induced nausea and vomiting is one of the most worrisome adverse effects of chemotherapy for cancer patients. It can cause severe discomfort and affect the quality of life. In recent years, the incorporation of new drugs has increased the efficacy of antiemetic treatments in the control of emesis associated with chemotherapy. This guideline, in which we give some treatment recommendations with level of evidence and grade of recommendation, provides an update of the previously published guideline of the Spanish Society of Medical Oncology and represents our continued commitment to improving supportive care in cancer patients.
Description
MeSH Terms
DeCS Terms
CIE Terms
Keywords
Chemotherapy-induced emesis, Antiemetic drugs, Prophylaxis of emesis, SEOM guidelines of antiemetic drugs, Efficacy, Emetogenicity, Palonosetron, Combination, Netupitant, Safety, Nepa